The U.S. Food and Drug Administration (FDA) has issued an approval for application number ANDA 086865. The submission, made by Watson Labs, was an original (ORIG) filing and received an approval status (AP) on September 24, 1984.
The approved product is an oral tablet containing chlorpropamide 100 mg. It is identified under the brand name CHLORPROPAMIDE, product number 001, and is listed with a marketing status of Discontinued.
No reference drug or reference standard was cited for this ANDA.
Regulatory UpdatesAug 30, 2026•1 min read
FDA Approves ANDA 086865 for Chlorpropamide Tablet (Discontinued)
The FDA granted approval (ANDA 086865) for Watson Labs' oral chlorpropamide 100 mg tablet, which is currently listed as discontinued.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating